Low triiodothyronine and cardiomyopathy in patients with end-stage renal disease
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
OBJECTIVES AND METHODS: Low free plasma triiodothyronine (fT3) is associated with inflammation and cardiovascular damage in patients with end-stage renal disease (ESRD). We investigated the relationship between fT3, left ventricular systolic function and left ventricular mass in a group of 234 dialysis patients, and modelled the association between fT3 and cardiomyopathy in statistical analyses including both direct (interleukin-6 and C-reactive protein) and inverse (serum albumin) acute phase inflammation markers. RESULTS: Plasma fT3 concentration in dialysis patients was significantly (P < 0.001) reduced in comparison with healthy participants and clinically euthyroid patients with normal renal function. Left ventricular systolic function was depressed (P <or= 0.003) and left ventricular mass increased (P < 0.001) in patients in the first fT3 quartile as compared with patients in other quartiles. In multiple regression analyses these associations remained significant also after adjustment for Framingham risk factors and antihypertensive therapy (P </= 0.01), and for risk factors peculiar to ESRD (P = 0.03). Adjustments for interleukin-6 or for albumin, however, abrogated these relationships. CONCLUSIONS: Low triiodothyronine is associated with left ventricular dysfunction and left ventricular hypertrophy in ESRD patients. These associations appear largely mediated by inflammation. Low fT3 may be an intermediate mechanism implicated in the adverse cardiac effects of inflammation in patients with ESRD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thyroid hormone and the cardiovascular system.
Klein, I., & Ojamaa, K. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102153440707 · Cited by 2,300
Dangerous dogmas in medicine: the nonthyroidal illness syndrome
De Groot, L. J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.1.5364 · Cited by 505
Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease
Iervasi, G., Pingitore, A., Landi, P., Raciti, M., Ripoli, A., Scarlattini, M., L’Abbate, A., & Donato, L. (2003) · Circulation · doi:10.1161/01.cir.0000048124.64204.3f · Cited by 472
de Simone, G., Devereux, R. B., Koren, M. J., Mensah, G. A., Casale, P. N., & Laragh, J. H. (1996) · Circulation · doi:10.1161/01.cir.93.2.259 · Cited by 374
Monzani, F., Di Bello, V., Caraccio, N., Bertini, A., Giorgi, D., Giusti, C., & Ferrannini, E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7291 · Cited by 308
Association between serum interleukin-6 and serum 3,5,3'-triiodothyronine in nonthyroidal illness.
Boelen, A., Platvoet-Ter Schiphorst, M. C., & Wiersinga, W. M. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.6.8263160 · Cited by 196
Triiodothyronine levels for risk stratification of patients with chronic heart failure
Pingitore, A., Landi, P., Taddei, M. C., Ripoli, A., L’Abbate, A., & Iervasi, G. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.07.052 · Cited by 192
Boelen, A., Maas, M. A., Lowik, C. W., Platvoet, M. C., & Wiersinga, W. M. (1996) · Endocrinology · doi:10.1210/endo.137.12.8940342 · Cited by 108
Cited by
Stenvinkel, P., Carrero, J. J. A. A., Axelsson, J., Lindholm, B., Heimbu[Combining Diaeresis]rger, O., & Massy, Z. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03670807 · Cited by 561
Inflammation in End-Stage Renal Disease-What Have We Learned in 10 Years?
Carrero, J. J., & Stenvinkel, P. (2010) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2010.00784.x · Cited by 354
Prevalence of Subclinical Hypothyroidism in Patients with Chronic Kidney Disease
Chonchol, M., Lippi, G., Salvagno, G., Zoppini, G., Muggeo, M., & Targher, G. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00800208 · Cited by 267
The interaction between thyroid and kidney disease: an overview of the evidence.
Rhee, C. M. (2016) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000275 · Cited by 135
Thyroid Function, Cardiovascular Events, and Mortality in Diabetic Hemodialysis Patients
Drechsler, C., Schneider, A., Gutjahr-Lengsfeld, L., Kroiss, M., Carrero, J. J., Krane, V., Allolio, B., Wanner, C., & Fassnacht, M. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.10.009 · Cited by 70
Metadata
- Authors
- Zoccali, C., Benedetto, F., Mallamaci, F., Tripepi, G., Cutrupi, S., Pizzini, P., Malatino, L. S., Bonanno, G., & Seminara, G.
- Venue
- Journal of Hypertension
- Published
- 2006-10
- Volume
- 24
- Issue
- 10
- Pages
- 2039-2046
- ISSN
- 0263-6352 (ISSN-L)
- OpenAlex
- W2070091622
- Cited by
- 68
- References
- 8
- FWCI
- 1.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Low triiodothyronine and cardiomyopathy in patients with end-stage renal disease. https://app.cochat.ai/papers/10.1097/01.hjh.0000244954.62362.8f
- The paper
- Zoccali, C., Benedetto, F., Mallamaci, F., Tripepi, G., Cutrupi, S., Pizzini, P., Malatino, L. S., Bonanno, G., & Seminara, G. (2006). Low triiodothyronine and cardiomyopathy in patients with end-stage renal disease. Journal of Hypertension. https://doi.org/10.1097/01.hjh.0000244954.62362.8f
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.